Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast Cancer.

about

Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast Cancer.

Item

http://www.wikidata.org/entity/Q47321009

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Targeted Intraoperative Radiot ...... e HER2-Negative Breast Cancer.

@en

Targeted Intraoperative Radiot ...... e HER2-Negative Breast Cancer.

@nl

type

Item

label

Targeted Intraoperative Radiot ...... e HER2-Negative Breast Cancer.

@en

Targeted Intraoperative Radiot ...... e HER2-Negative Breast Cancer.

@nl

prefLabel

Targeted Intraoperative Radiot ...... e HER2-Negative Breast Cancer.

@en

Targeted Intraoperative Radiot ...... e HER2-Negative Breast Cancer.

@nl

P1476

Targeted Intraoperative Radiot ...... e HER2-Negative Breast Cancer.

@en

P2093

Cornelia Liedtke

http://www.w3.org/2001/XMLSchema#string

György Lövey

http://www.w3.org/2001/XMLSchema#string

Hans-Christian Kolberg

http://www.w3.org/2001/XMLSchema#string

Jayant Vaidya

http://www.w3.org/2001/XMLSchema#string

Leyla Akpolat-Basci

http://www.w3.org/2001/XMLSchema#string

Max Bulsara

http://www.w3.org/2001/XMLSchema#string

Miltiades Stephanou

http://www.w3.org/2001/XMLSchema#string

Oliver Hoffmann

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding

Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery.

Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.

Genomic grade index is associated with response to chemotherapy in patients with breast cancer.

Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.

Intraoperative radiotherapy (IORT) as boost in breast cancer.

Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.

Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy.

Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.

P304

318-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000479424

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Untch

Peter A. Fasching

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29234252

http://www.w3.org/2001/XMLSchema#string

P932

5704703

http://www.w3.org/2001/XMLSchema#string